News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
7,847 Results
Type
Article (319)
Company Profile (8)
Press Release (7520)
Section
Business (2203)
Career Advice (24)
Deals (336)
Drug Development (977)
Employer Resources (4)
FDA (141)
Job Trends (267)
News (3611)
Policy (400)
Tag
2027 Pharm Country Standard (1)
Academia (78)
Allergies (2)
Alliances (600)
ALS (8)
Alzheimer's disease (21)
Approvals (146)
Artificial intelligence (18)
Autoimmune disease (2)
Bankruptcy (1)
Best Places to Work (256)
Biotechnology (3)
Bladder cancer (3)
Brain cancer (1)
Breast cancer (21)
Cancer (117)
Cardiovascular disease (12)
Career advice (23)
CAR-T (2)
Cell therapy (8)
Cervical cancer (3)
Clinical research (866)
Collaboration (41)
Compensation (8)
Complete response letters (1)
COVID-19 (53)
C-suite (18)
Cystic fibrosis (8)
Data (94)
Depression (14)
Diabetes (2)
Diagnostics (65)
Digital health (2)
Diversity (1)
Diversity, equity & inclusion (2)
Duchenne muscular dystrophy (4)
Earnings (642)
Employer resources (4)
Events (1237)
Executive appointments (17)
FDA (194)
Frontotemporal dementia (3)
Funding (23)
Gene therapy (10)
GLP-1 (2)
Government (94)
Guidances (9)
Healthcare (751)
IgA nephropathy (2)
Immunology and inflammation (2)
Immuno-oncology (3)
Indications (2)
Infectious disease (53)
Inflammatory bowel disease (1)
Intellectual property (2)
Interviews (2)
IPO (167)
Job creations (14)
Job search strategy (20)
JPM (2)
Kidney cancer (2)
Layoffs (4)
Leadership (1)
Legal (59)
Liver cancer (7)
Lung cancer (2)
Lymphoma (13)
Machine learning (2)
Management (2)
Manufacturing (8)
Medical device (186)
Medtech (186)
Mergers & acquisitions (185)
Metabolic disorders (7)
Multiple sclerosis (3)
Neurodegenerative disease (6)
Neuropsychiatric disorders (9)
Neuroscience (61)
NextGen: Class of 2026 (226)
Non-profit (202)
Obesity (5)
Opinion (7)
Ovarian cancer (1)
Pain (5)
Pancreatic cancer (3)
Parkinson's disease (1)
Patents (3)
Patient recruitment (11)
People (779)
Pharmaceutical (2)
Phase 1 (208)
Phase 2 (437)
Phase 3 (371)
Pipeline (96)
Policy (4)
Postmarket research (25)
Preclinical (62)
Prostate cancer (6)
Psychedelics (17)
Radiopharmaceuticals (6)
Rare diseases (32)
Real estate (115)
Regulatory (331)
Research institute (108)
Resumes & cover letters (2)
Schizophrenia (1)
Series A (4)
Series B (2)
Sickle cell disease (1)
Special edition (1)
Spinal muscular atrophy (4)
Sponsored (1)
Startups (34)
Supply chain (3)
Tariffs (2)
The Weekly (3)
Vaccines (8)
Venture capital (1)
Weight loss (2)
Women's health (3)
Worklife (1)
Date
Last 7 days (14)
Last 30 days (41)
Last 365 days (528)
2026 (58)
2025 (527)
2024 (516)
2023 (655)
2022 (615)
2021 (708)
2020 (923)
2019 (1024)
2018 (713)
2017 (281)
2016 (279)
2015 (288)
2014 (220)
2013 (172)
2012 (148)
2011 (130)
2010 (87)
Location
Africa (12)
Alabama (2)
Arizona (5)
Arkansas (1)
Asia (336)
Australia (90)
California (109)
Canada (79)
China (5)
Colorado (6)
Connecticut (11)
Delaware (2)
Europe (1003)
Florida (48)
Georgia (11)
Idaho (2)
Illinois (59)
Indiana (5)
Japan (2)
Kansas (1)
Kentucky (2)
Louisiana (2)
Maryland (10)
Massachusetts (178)
Michigan (1)
Minnesota (9)
Nevada (3)
New Jersey (54)
New York (75)
North Carolina (15)
Northern California (62)
Ohio (8)
Oregon (3)
Pennsylvania (22)
Puerto Rico (1)
Rhode Island (1)
South America (10)
South Carolina (2)
Southern California (38)
Tennessee (8)
Texas (22)
United States (675)
Utah (5)
Virginia (7)
Washington State (8)
Wisconsin (1)
7,847 Results for "compass therapeutics.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Psychedelics
Psychedelics Space at a ‘Tipping Point’ as Compass, Definium Gear Up To File for Approval
With Lykos’ regulatory failure now squarely in the rearview mirror, Compass Pathways and Definium are leading what one analyst suspects will be “a very big year for psychedelics.”
February 2, 2026
·
7 min read
·
Heather McKenzie
Press Releases
Compass Therapeutics Provides Corporate Update
January 6, 2026
·
9 min read
Press Releases
Compass Therapeutics Announces Key Leadership Appointments
January 5, 2026
·
5 min read
Press Releases
COMPASS SURGICAL PARTNERS AND CARDIOVASCULAR INSTITUTE OF NORTHWEST FLORIDA BRING FIRST OUTPATIENT CATH LAB TO REGION
January 29, 2026
·
2 min read
Press Releases
Compass Therapeutics to Participate in the J.P. Morgan 2026 Healthcare Conference
December 17, 2025
·
1 min read
Press Releases
Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD
January 7, 2026
·
12 min read
Press Releases
Compass Therapeutics to Participate in Upcoming December 2025 Investor Events
November 26, 2025
·
1 min read
Press Releases
Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - January 5, 2026
January 6, 2026
·
2 min read
Press Releases
Compass Pathways to Participate in Stifel 2025 Healthcare Conference
November 5, 2025
·
1 min read
Press Releases
Compass Pathways Establishes Strategic Collaboration with Radial to Innovate Patient Experience and Inform Potential Delivery Model of COMP360
January 6, 2026
·
7 min read
1 of 785
Next
